Follow The Filings

SUPN position history

The shares of Supernus Pharmaceuticals (SUPN) that THIRD AVENUE MANAGEMENT LLC reported in each quarter’s 13F.

Equity, COM

Shares held by quarter

New Add Reduce Exit

  1. 2022 Q2: 2,460 shares, $72K, 0.01% of portfolio, New
  2. 2022 Q3: 2,460 shares, $84K, 0.02% of portfolio
  3. 2022 Q4: 2,460 shares, $88K, 0.02% of portfolio
  4. 2023 Q1: 4,920 shares, $178K, 0.03% of portfolio, Add +100.0%
  5. 2023 Q2: 67,062 shares, $2M, 0.33% of portfolio, Add +1263.0%
  6. 2023 Q3: 116,549 shares, $3.3M, 0.55% of portfolio, Add +73.8%
  7. 2023 Q4: 159,717 shares, $4.6M, 0.76% of portfolio, Add +37.0%
  8. 2024 Q1: 159,717 shares, $5.4M, 0.87% of portfolio
  9. 2024 Q2: 189,118 shares, $5.1M, 0.87% of portfolio, Add +18.4%
  10. 2024 Q3: 189,493 shares, $5.9M, 0.97% of portfolio, Add +0.2%
  11. 2024 Q4: 189,493 shares, $6.9M, 1.3% of portfolio
  12. 2025 Q1: 189,493 shares, $6.2M, 1.2% of portfolio
  13. 2025 Q2: 189,493 shares, $6M, 1.2% of portfolio
  14. 2025 Q3: 189,493 shares, $9.1M, 1.7% of portfolio
  15. 2025 Q4: 189,493 shares, $9.4M, 1.7% of portfolio
  16. 2026 Q1: 152,724 shares, $7.9M, 1.3% of portfolio, Reduce −19.4%
  17. 2026 Q2: 152,724 shares, $7.1M, 1.1% of portfolio
  18. 2026 Q3: 157,150 shares, $6.8M, 1.1% of portfolio, Add +2.9%
Holdings date Value % of holdings Shares Filing date All 13F holders